Dawn Bell
Directeur/Membre du Conseil chez STRM.Bio, Inc.
Postes actifs de Dawn Bell
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
STRM.Bio, Inc.
 STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Directeur/Membre du Conseil | 17/05/2023 | - |
Historique de carrière de Dawn Bell
Formation de Dawn Bell
| University of Florida | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
STRM.Bio, Inc.
STRM.Bio, Inc. BiotechnologyHealth Technology STRM.Bio, Inc. is a pre-clinical biotechnology company based in Cambridge, MA. The company's goal is to make gene therapy safe for repeat dosing and to provide a future of medicine for patients with rare diseases worldwide. The company, which was founded by Jonathan Thon and has had him as CEO since incorporation, is backed by venture capital and focuses on developing and delivering targeted gene therapies using extracellular vesicles. | Health Technology |
